🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Ipsen Pharma — Licensed Medicines

21 medicines held by Ipsen Pharma on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 21 products held by Ipsen Pharma
MedicineActive substanceLicence holderStatus
Alluzience, 200 Speywood units/mL, solution for injection
PA1613/004/001
Botulinum Toxin A - Haemagglutinin Complex Ipsen Pharma Marketed
Azzalure, 125 Speywood units, powder for solution for injection
PA1613/001/001
Clostridium botulinum toxin type a haemagglutinin complex Ipsen Pharma Marketed
Bylvay 1 200 micrograms hard capsules
EU/1/21/1566/004
Odevixibat sesquihydrate Ipsen Pharma
Bylvay 200 micrograms hard capsules
EU/1/21/1566/001
Odevixibat sesquihydrate Ipsen Pharma
Bylvay 400 micrograms hard capsules
EU/1/21/1566/002
Odevixibat sesquihydrate Ipsen Pharma
Bylvay 600 micrograms hard capsules
EU/1/21/1566/003
Odevixibat sesquihydrate Ipsen Pharma
CABOMETYX 20 mg film-coated tablets
EU/1/16/1136/001-002
Cabozantinib Ipsen Pharma
CABOMETYX 40 mg film-coated tablets
EU/1/16/1136/003-004
Cabozantinib Ipsen Pharma
CABOMETYX 60 mg film-coated tablets
EU/1/16/1136/005-006
Cabozantinib Ipsen Pharma
COMETRIQ 20 mg hard capsules
EU/1/13/890/001
Cabozantinib (s)-malate Ipsen Pharma
COMETRIQ 80 mg hard capsules
EU/1/13/890/002-003
Cabozantinib (s)-malate Ipsen Pharma
Dysport 300 units Powder for solution for injection
PA1613/002/002
Botulinum toxin type A - haemagglutinin complex Ipsen Pharma Marketed
Dysport 500 units Powder for solution for injection
PA1613/002/001
Clostridium botulinum toxin type a haemagglutinin complex Ipsen Pharma Marketed
Iqirvo 80 mg film-coated tablets
EU/1/24/1855/001
Elafibranor Ipsen Pharma
KAYFANDA 1200 microgram hard capsules
EU/1/24/1854/004
Odevixibat Ipsen Pharma
KAYFANDA 200 microgram hard capsules
EU/1/24/1854/001
Odevixibat Ipsen Pharma
KAYFANDA 400 microgram hard capsules
EU/1/24/1854/002
Odevixibat Ipsen Pharma
KAYFANDA 600 microgram hard capsules
EU/1/24/1854/003
Odevixibat Ipsen Pharma
NutropinAq 10 mg/2 ml solution for injection
EU/1/00/164/003-004
Somatropin Ipsen Pharma
NutropinAq 10 mg/2 ml solution for injection
EU/1/00/164/005
Somatropin Ipsen Pharma
Relfydess, 100 units/mL, solution for injection
PA1613/005/001
Botulinum Toxin Type A Ipsen Pharma Marketed

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.